from Viromed Medical AG (isin : DE000A3MQR65)
EQS-Adhoc: Viromed Medical AG completes acquisition of pharmedix GmbH
EQS-Ad-hoc: Viromed Medical AG / Key word(s): Takeover/Mergers & Acquisitions
Viromed Medical AG completes acquisition of pharmedix GmbH
20-Dec-2024 / 14:05 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Viromed Medical AG completes acquisition of pharmedix GmbH
- Notarial purchase agreement signed today
- Consolidated revenues are expected to multiply to a low double-digit million euro amount in fiscal year 2025.
Pinneberg, 20 December 2024 – Today, Viromed Medical AG (Ticker: VMED; ISIN: DE000A3MQR65) completed the announced acquisition of pharmedix GmbH by notarized purchase agreement. The acquisition is effective as of 1 January 2025. Following the successful acquisition of pharmedix GmbH, Viromed Medical AG now expects consolidated revenues in the low double-digit million euro range for the 2025 financial year, a significant increase over the previous year.
Contact Viromed Medical AG
Uwe Perbandt
CEO
Flensburger Straße 18
25421 Pinneberg
E-Mail: kontakt@viromed-medical.de
www.viromed-medical-ag.de
End of Inside Information
20-Dec-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
| Language: | English |
| Company: | Viromed Medical AG |
| Flensburger Straße 18 | |
| 25421 Pinneberg | |
| Germany | |
| Phone: | +49 4101 809960 |
| E-mail: | kontakt@viromed-medical.de |
| Internet: | https://www.viromed-medical-ag.de/ |
| ISIN: | DE000A3MQR65 |
| WKN: | A3MQR6 |
| Listed: | Regulated Unofficial Market in Berlin, Dusseldorf (Primärmarkt), Frankfurt (Basic Board), Hamburg |
| EQS News ID: | 2056023 |
| End of Announcement | EQS News Service |
2056023 20-Dec-2024 CET/CEST